Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 5/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 4/20 | 0.31 |
| ▸ | CA4 | P22748 | 4/20 | 0.31 |
| ▸ | CA9 | Q16790 | 4/20 | 0.31 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18001172 | 0.88 | FURIN (0.32) | FURIN | |
| SCHEMBL18015097 | 0.88 | GAA (0.39) | FURINCA2 | |
| SCHEMBL18001594 | 0.84 | CA2 (0.32) | CA2 | |
| SCHEMBL18015096 | 0.76 | GAA (0.36) | CA2LMNAPOLBCA1CA4 | |
| SCHEMBL18015095 | 0.76 | GAA (0.43) | FURINCA2 | |
| SCHEMBL15053148 | 0.73 | CYP19A1 (0.50) | FURINLMNAPOLB | |
| SCHEMBL6846692 | 0.73 | FURIN (0.44) | FURINLMNACA9CYP1A2 | |
| SCHEMBL2704783 | 0.73 | MEN1 (0.47) | FURINLMNACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL2067685 | 0.73 | FURIN (0.44) | FURINLMNACA9CYP1A2 | |
| SCHEMBL21164826 | 0.72 | ALDH1A1 (0.37) | LMNAPOLBMETTL3CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10351662-B2 | Degradable hydrazone curing agents and applications thereof | ADESSO ADVANCED MATERIALS WUHU CO., LTD. (CN) | 2019-07-16 | — | — | US | disclosed |
| US-20160264718-A1 | DEGRADABLE HYDRAZONE CURING AGENTS AND APPLICATIONS THEREOF | ADESSO ADVANCED MATERIALS WUXI CO., LTD. (CN) | 2016-09-15 | — | — | US | disclosed |
| US-20160264718-A1 | DEGRADABLE HYDRAZONE CURING AGENTS AND APPLICATIONS THEREOF | ADESSO ADVANCED MATERIALS WUXI CO., LTD. (CN) | 2016-09-15 | — | — | US | disclosed |
| US-20160229949-A1 | DEGRADABLE HYDRAZONE CURING AGENTS AND APPLICATIONS THEREOF | ADESSO ADVANCED MATERIALS WUXI CO., LTD. (CN) | 2016-08-11 | — | — | US | disclosed |
| US-20160229949-A1 | DEGRADABLE HYDRAZONE CURING AGENTS AND APPLICATIONS THEREOF | ADESSO ADVANCED MATERIALS WUXI CO., LTD. (CN) | 2016-08-11 | — | — | US | disclosed |
| WO-2015043462-A1 | DEGRADABLE HYDRAZONE CURING AGENTS AND APPLICATIONS THEREOF | ADESSO ADVANCED MATERIALS WUXI CO., LTD. (CN) | 2015-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351662-B2 | Degradable hydrazone curing agents and applications thereof | EGLN2, EGLN3, P4HA1 | FURIN 412/4885CA2 1218/4885LMNA 52/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.